Nygaard V, Ree AH, Dagenborg VJ, Børresen-Dale AL, Edwin B, Fretland ÅA, Grzyb K, Haugen MH, Mælandsmo GM, Flatmark K(2023) A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases Cancer Res Commun, 3(2), 235-244 DOI 10.1158/2767-9764.CRC-22-0295, PubMed 36968142
Silwal-Pandit L, Stålberg SM, Johansson HJ, Mermelekas G, Lothe IMB, Skrede ML, Dalsgaard AM, Nebdal DJH, Helland Å, Lingjærde OC, Labori KJ, Skålhegg BS, Lehtiö J, Kure EH(2022) Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome Cancer Res Commun, 2(6), 434-446 DOI 10.1158/2767-9764.CRC-21-0100, PubMed 36923555
Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA(2022) Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial Nat Med, 28(12), 2573-2583 DOI 10.1038/s41591-022-02126-1, PubMed 36482103
